丽珠医药 内部交易概览
暂无关于该公司的高管股东内部交易数据
暂无关于该公司18月以内的内部交易数据
丽珠医药 内部交易
丽珠医药 最新内部交易
徐国祥 | Directors, executives | 2019-11-27 | 买入 | 98,000 | - |
¥31.02
|
+27.05%
|
司燕霞 | Executives | 2019-10-24 | 买入 | 20,000 | 262,400 |
¥27.27
|
+44.52%
|
杨亮 | Secretary Dong | 2019-10-24 | 买入 | 4,700 | 120,000 |
¥27.3
|
+44.36%
|
唐阳刚 | Directors, executives | 2019-10-24 | 买入 | 200,000 | 203,000 |
¥27.41
|
+43.78%
|
周鹏 | Executives | 2019-10-23 | 买入 | 27,000 | 166,500 |
¥27.85
|
+41.51%
|
黄华敏 | Supervisors | 2018-10-10 | 卖出 | 1,690 | - |
¥24.5
|
+60.86%
|
杨代宏 | Executives | 2018-06-04 | 买入 | 286 | - |
¥38.99
|
+1.08%
|
黄华敏 | Supervisors | 2018-01-12 | 卖出 | 2,285 | - |
¥42.93
|
-8.20%
|
周鹏 | Executives | 2017-11-07 | 卖出 | 2,570 | - |
¥44.97
|
-12.36%
|
徐国祥 | Directors, executives | 2017-10-13 | 卖出 | 118,528 | - |
¥34.09
|
+15.61%
|